Cartesian Therapeutics Insider Trades
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $205.80K
- Sales
- 3 · $258.67K
- Shares bought / sold
- 30.00K / 37.93K
- Net activity
- Net selling $52,874
Cartesian Therapeutics insider activity
Over the last 12 months, Cartesian Therapeutics insiders reported 23 transactions on SEC Form 4: 1 open-market purchase and 3 sales. Insiders bought $205,797 and sold $258,671 worth of stock, for net insider selling of $52,874. The largest seller was Brunn Carsten, with $162,077 in reported sales.
The most recent filing shows Hoge Elizabeth & Seven One Eight Three Four Irrevocable Trust (10% Owner) reporting a transaction in 758,001 shares on Apr 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RNAC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RNAC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 2, 2026 | Kalayoglu Murat10% Owner | Option exercise | 758,001 | — | Form 4 |
| Apr 2, 2026 | Hoge Elizabeth & Seven One Eight Three Four Irrevocable Trust10% Owner | Option exercise | 758,001 | — | Form 4 |
| Mar 13, 2026 | Singer MichaelDirector | Gift | 6,555 | — | Form 4 |
| Jan 6, 2026 | Brunn CarstenPresident and CEO | Sale | 23,766 | $162.08K | Form 4 |
| Jan 6, 2026 | Davis BlaineChief Financial Officer | Sale | 10,591 | $72.23K | Form 4 |
| Jan 6, 2026 | Miljkovic MilosChief Medical Officer | Sale | 3,573 | $24.37K | Form 4 |
| Jan 2, 2026 | Kalayoglu MuratDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | SPRINGER TIMOTHY ADirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | Singer MichaelDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | English EmilyChief Operations Officer | Award | 24,000 | — | Form 4 |
| Jan 2, 2026 | Seymour June AnnChief Accounting Officer | Award | 6,500 | — | Form 4 |
| Jan 2, 2026 | ZENNER PATRICK JDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | BARABE TIMOTHY CDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | Davis BlaineChief Financial Officer | Award | 37,000 | — | Form 4 |
| Jan 2, 2026 | Malik KemalDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | DeSilva Nishan MDirector | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | Miljkovic MilosChief Medical Officer | Award | 27,000 | — | Form 4 |
| Jan 2, 2026 | Brunn CarstenPresident and CEO | Award | 143,200 | — | Form 4 |
| Dec 30, 2025 | English EmilyChief Operations Officer | Option exercise | 7,500 | $24.75K | Form 4 |
| Dec 16, 2025 | Bot Adrian IonDirector | Award | 5,800 | — | Form 4 |
| Dec 4, 2025 | BARABE TIMOTHY CDirector | Buy | 30,000 | $205.80K | Form 4 |
| Nov 28, 2025 | English EmilyChief Operations Officer | Option exercise | 7,500 | $24.75K | Form 4 |
| Nov 18, 2025 | Singer MichaelDirector | Gift | 20,000 | — | Form 4 |
| May 12, 2025 | English EmilyChief Operations Officer | Option exercise | 7,500 | $24.75K | Form 4 |
| Apr 15, 2025 | English EmilyChief Operations Officer | Option exercise | 7,500 | $24.75K | Form 4 |
| Apr 11, 2025 | SPRINGER TIMOTHY ADirector | Buy | 36,338 | $391.45K | Form 4 |
| Apr 11, 2025 | SPRINGER TIMOTHY ADirector | Buy | 6,412 | $69.07K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY ADirector | Buy | 3,451 | $37.70K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY ADirector | Buy | 45,144 | $471.06K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY ADirector | Buy | 609 | $6.65K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY ADirector | Buy | 7,966 | $83.12K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY ADirector | Buy | 178 | $1.77K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY ADirector | Buy | 41,604 | $392.18K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY ADirector | Buy | 31 | $308.48 | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY ADirector | Buy | 7,342 | $69.21K | Form 4 |
| Mar 20, 2025 | SPRINGER TIMOTHY ADirector | Buy | 54,889 | $855.59K | Form 4 |
| Mar 19, 2025 | SPRINGER TIMOTHY ADirector | Buy | 20,234 | $302.96K | Form 4 |
| Mar 18, 2025 | SPRINGER TIMOTHY ADirector | Buy | 14,740 | $212.60K | Form 4 |
| Jan 14, 2025 | SPRINGER TIMOTHY ADirector | Buy | 4,022 | $72.40K | Form 4 |
| Jan 13, 2025 | SPRINGER TIMOTHY ADirector | Buy | 8,983 | $159.74K | Form 4 |
| Jan 13, 2025 | SPRINGER TIMOTHY ADirector | Buy | 7,962 | $134.22K | Form 4 |
| Jan 10, 2025 | Jewell Christopher MChief Scientific Officer | Option exercise | 9,000 | $29.07K | Form 4 |
| Jan 6, 2025 | Davis BlaineChief Financial Officer | Sale | 4,028 | $67.80K | Form 4 |
| Jan 6, 2025 | Brunn CarstenPresident and CEO | Sale | 8,708 | $146.57K | Form 4 |
| Jan 6, 2025 | English EmilyChief Operations Officer | Sale | 906 | $15.25K | Form 4 |
| Jan 6, 2025 | Jewell Christopher MChief Scientific Officer | Sale | 1,286 | $21.65K | Form 4 |
| Jan 6, 2025 | Miljkovic MilosChief Medical Officer | Sale | 948 | $15.96K | Form 4 |
| Jan 6, 2025 | Kurtoglu MetinChief Technology Officer | Sale | 2,458 | $41.37K | Form 4 |
| Jan 3, 2025 | Davis BlaineChief Financial Officer | Sale | 3,961 | $66.24K | Form 4 |
| Jan 3, 2025 | Brunn CarstenPresident and CEO | Sale | 8,563 | $143.19K | Form 4 |
| Jan 3, 2025 | English EmilyChief Operations Officer | Sale | 891 | $14.90K | Form 4 |
| Jan 3, 2025 | Jewell Christopher MChief Scientific Officer | Sale | 1,264 | $21.14K | Form 4 |
| Jan 3, 2025 | Miljkovic MilosChief Medical Officer | Sale | 932 | $15.58K | Form 4 |
| Jan 3, 2025 | Kurtoglu MetinChief Technology Officer | Sale | 2,417 | $40.42K | Form 4 |
| Jan 2, 2025 | Davis BlaineChief Financial Officer | Award | 22,000 | — | Form 4 |
| Jan 2, 2025 | English EmilyChief Operations Officer | Award | 16,100 | — | Form 4 |
| Jan 2, 2025 | Jewell Christopher MChief Scientific Officer | Award | 16,100 | — | Form 4 |
| Jan 2, 2025 | Brunn CarstenPresident and CEO | Award | 57,500 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4